Maybe the company is simply looking to cover its bases and secure the legal rights to a number of
generic marketing labels it could actually end up using someday... or not.
Not exact matches
When low - cost
generic fluoxetine became available, its use increased in the veterinary
market and in 2007 Eli Lilly released a version of fluoxetine specifically
labeled for animal use and sponsored a behavioral program to go with it.
In practice, it is usually the first approved indication that is free of exclusivity protection earlier in time and
generics, while submitting drug applications for an early
market entry, carve out the subsequent indications from the
label to avoid potential infringement of patents which may cover the new approved indications.